Table 1.
Analysis of the positive patients group
| Patient code | Age |
Positivie test = 1 Negative test = 0 |
Delta DE | PSA | ALL [DE-PSA] <−10.52 | Delta DE ≤−0.5 | PSA ≥−4 | ALL [DE – PSA] ≤ 10.52 | Current treatment |
|---|---|---|---|---|---|---|---|---|---|
| 1ZH05 | 57 | 1 | −6 | 200.2 | −1201.2 | X | X | X | No treatment |
| 1ZM13 | 90 | 1 | 2 | 45 | 90 | X | Diuretics/furosemide | ||
| 1ZD19 | 67 | 1 | −9 | 26.0 | −234 | X | X | X | ACE |
| 1ZL06 | 79 | 1 | −4 | 4.4 | −17.6 | X | X | No treatment | |
| 1Zd26 | 62 | 1 | −3 | 19 | −57 | X | X | Diuretics/furosemide | |
| 1ZS19 | 66 | 1 | −8 | 3.1 | −24.8 | X | X | No treatment | |
| 1ZT15 | 64 | 1 | −8 | 11 | −88 | X | X | X | No treatment |
| 1ZA31 | 69 | 1 | −6 | 3.0 | −18.06 | X | X | No treatment | |
| 1ZL01 | 89 | 1 | −6 | 4.1 | −24.6 | X | X | X | ACE, insulin NPH |
| 1ZB08 | 76 | 1 | −10 | 3.5 | −35 | X | X | ACE, diuretics | |
| 1ZC30 | 56 | 1 | −8 | 3.5 | −28 | X | X | No treatment | |
| 1ZA10 | 52 | 1 | −8 | 3.3 | −26.4 | X | X | Simvastatin, omeprazole | |
| 1ZF06 | 84 | 1 | −2 | 7.5 | −15 | X | X | ACE, ranitidine | |
| 1ZS04 | 80 | 1 | −4 | 14 | −56 | X | X | Diuretics, ACE | |
| 1ZF03 | 57 | 1 | −8 | 2.3 | −18.4 | X | X | Angiotensin II antagonists, Crestor | |
| 1ZS02 | 62 | 1 | −5 | 14.0 | −70 | X | X | X | No treatment |
| 1Zx17 | 68 | 1 | −1 | 4.9 | −4.9 | X | ACE, diuretics | ||
| 1ZS28 | 76 | 1 | −6 | 319 | −1914 | X | X | X | Metformin ACE, Diuretics |
| 1ZD22 | 74 | 1 | −10 | 6.5 | −65 | X | X | X | ACE, simvastatin |
| 1ZR25 | 50 | 1 | −2 | 5.26 | −10.52 | X | X | No treatment | |
| 1ZF28 | 71 | 1 | −5 | 6.0 | −30 | X | X | X | No treatment |
| 1ZM11 | 59 | 1 | −2 | 9 | −18 | X | X | Alpha blockers | |
| 1WR28 | 55 | 1 | −5 | 4.2 | −21 | X | X | X | ACE, selozok |
Note: X = Right results in reference to the biopsies.